TABLE 3.

Sensitivity of TbF6 in combinations with Mtb81 and DPEP with HIV-TB sera (pretreatment) and sera from other disease categories

Patient statusaSourcenSmearNo. (%) positive
TbF6 + DPEPMtb81TbF6 + DPEP + Mtb81
HIV+-TB+Sub-Saharan Africac59+294649
5155
Total6430 (46.9)51 (79.7)54 (84.4)
HIV−-TB+Sub-Saharan Africa66+47 (71.2)38 (57.6)56 (84.8)
HIV+-TB−United States11000
PPD+bAfrica-Europe-Asia-Americas57324
PPD−bAfrica-Europe-Asia-Americas29101
Lung cancerChina13000
Bone cancerChina4000
Non-TB lung infectionsChina/Caucasian18011
HealthyChina/Caucasian9000
  • a +, positive; −, negative.

  • b See Table 2 for geographical distribution.

  • c Includes 2 extrapulmonary TB sera and 27 sera previously shown to be negative to the 38-kDa antigen.